Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 1, 2019
Primary Event: Regulation FD Disclosure (Item 7.01) regarding the furnishing of an investor presentation (Exhibit 99.1) for use in meetings with investors or analysts.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an investor presentation and does not contain audited or unaudited financial statements within the body of the text.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document is a procedural disclosure to make an investor presentation available to the public.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated October 1, 2019, which may be used in whole or in part at subsequent meetings.
Legal Disclaimer: The information in this report and the attached exhibit is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the investor presentation) for specific financial data, guidance, and strategic updates not included in this summary.
- Verify the trading symbol (TXMD) and exchange (The Nasdaq Stock Market LLC) for current market data.
- Confirm that the presentation content has not been superseded by more recent filings or press releases.
- Note that this filing does not constitute a formal financial report; rely on 10-K or 10-Q filings for audited financial metrics.